Literature DB >> 12409361

Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

B Madison1, B Robinson-Dunn, I George, W Gross, H Lipman, B Metchock, A Sloutsky, G Washabaugh, G Mazurek, J Ridderhof.   

Abstract

Reproducibility of ethambutol (EMB) susceptibility test results for Mycobacterium tuberculosis has always been difficult for a variety of reasons, including the narrow range between the critical breakpoint for EMB resistance and the MIC for susceptible strains, borderline results obtained with the BACTEC 460TB method, the presence of microcolonies determined using the agar proportion (AP) method, and a lack of agreement between these two testing methods. To assess the frequency of these problems, M. tuberculosis drug susceptibility data were collected in a multicenter study involving four laboratories. Resistant, borderline, and susceptible isolates were shared among the laboratories to measure interlaboratory test agreement. Half of isolates determined by BACTEC 460TB to be resistant were determined to be susceptible by the AP method. Isolates determined to be resistant to EMB by both BACTEC 460TB and AP methods were almost always resistant to isoniazid. Results from isolates tested by the BACTEC 460TB method with an EMB concentration of 3.75 micro g/ml in addition to the standard 2.5 micro g/ml did not show improved agreement by the AP method. While these results do not indicate that the AP method is more accurate than the BACTEC 460TB method, laboratories should not report EMB monoresistance based on BACTEC 460TB results alone. Monoresistance to EMB should only be reported following confirmation by the AP method. Microcolonies could not be confirmed as resistant by the BACTEC 460TB method or by repeat testing with the AP method and do not appear to be indicative of resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409361      PMCID: PMC139676          DOI: 10.1128/JCM.40.11.3976-3979.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparison of various measures of sensitivity of M. tuberculosis to ethambutol.

Authors:  S Subbammal; N G Nair; S Radhakrishna; S P Tripathy
Journal:  Tubercle       Date:  1978-09

2.  Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  J E Hawkins
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

3.  Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures.

Authors:  C L Woodley
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

4.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; J P Libonati; G Middlebrook
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

5.  Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique.

Authors:  G Vincké; O Yegers; H Vanachter; P A Jenkins; J P Butzler
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

6.  Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis.

Authors:  H L David
Journal:  Appl Microbiol       Date:  1970-11

7.  Influence of the medium on the in vitro susceptibility of Mycobacterium tuberculosis to ethambutol.

Authors:  P R Gangadharam; E R Gonzales
Journal:  Am Rev Respir Dis       Date:  1970-10

8.  Rapid radiometric susceptibility testing of Mycobacterium tuberculosis.

Authors:  J A Kertcher; M F Chen; P Charache; C C Hwangbo; E E Camargo; P A McIntyre; H N Wagner
Journal:  Am Rev Respir Dis       Date:  1978-04

9.  Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope.

Authors:  L Deng; K Mikusová; K G Robuck; M Scherman; P J Brennan; M R McNeil
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods.

Authors:  S H Siddiqi; J E Hawkins; A Laszlo
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

View more
  37 in total

1.  Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.

Authors:  David A J Moore; Daniel Mendoza; Robert H Gilman; Carlton A W Evans; María-Graciela Hollm Delgado; Jose Guerra; Luz Caviedes; Daniel Vargas; Eduardo Ticona; Jaime Ortiz; Giselle Soto; Jose Serpa
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 2.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

3.  Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.

Authors:  Pawan K Angra; Thomas H Taylor; Michael F Iademarco; Beverly Metchock; J Rex Astles; John C Ridderhof
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

4.  Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.

Authors:  J Esteban; A Ortiz; M S Jiménez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 5.  Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.

Authors:  Claudio Piersimoni; Armando Olivieri; Luca Benacchio; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

6.  Tuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping.

Authors:  Burkhard Springer; Romana C Calligaris-Maibach; Claudia Ritter; Erik C Böttger
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

7.  Rifampin drug resistance tests for tuberculosis: challenging the gold standard.

Authors:  Armand Van Deun; Kya J M Aung; Valentin Bola; Rossin Lebeke; Mohamed Anwar Hossain; Willem Bram de Rijk; Leen Rigouts; Aysel Gumusboga; Gabriela Torrea; Bouke C de Jong
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

8.  Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011-2016.

Authors:  Clarisse A Tsang; Neha Shah; Lori R Armstrong; Suzanne M Marks
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

9.  Comparison of TaqMan(®) Array Card and MYCOTB(TM) with conventional phenotypic susceptibility testing in MDR-TB.

Authors:  S Foongladda; S Banu; S Pholwat; J Gratz; S O-Thong; N Nakkerd; R Chinli; S S Ferdous; S M M Rahman; A Rahman; S Ahmed; S Heysell; M Sariko; G Kibiki; E Houpt
Journal:  Int J Tuberc Lung Dis       Date:  2016-08       Impact factor: 2.373

Review 10.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.